A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

NCT05135715 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma, Stage II
HER2-positive
Advanced Melanoma

Interventions

DRUG: RC48-ADC

Sponsor

RemeGen Co., Ltd.